1
/
of
1
Refametinib (R enantiomer) [CAS 923032-38-6]
Refametinib (R enantiomer) [CAS 923032-38-6]
SKU:QM-0000220
£290.57 GBP
Quantity
Couldn't load pickup availability
Request quote or documents
![Refametinib (R enantiomer) [CAS 923032-38-6]](http://quantimol.com/cdn/shop/files/quantimol-021.png?v=1773515276&width=1445)
Product Details
-
Description
Refametinib R enantiomer is a MEK inhibitor extracted from patent WO2007014011A2, compound 1022, has an EC50 of 2.0-15 nM.
-
CAS Number
[923032-38-6]
-
Molecular Formula
C19H20F3IN2O5S
-
Molecular Weight
572.34
-
Smiles
O=S(C1(C[C@H](CO)O)CC1)(NC(C(NC(C(F)=C2)=CC=C2I)=C3F)=C(OC)C=C3F)=O
-
Target
MEK
-
Isoform
MEK
-
Solubility
10 mM in DMSO
-
Shipping Conditions
Room temperature
-
Hazard Statement
H361-H372
-
Precautions
P260-P264-P270-P280-P405-P501
Related Products
- QM-0052086 Sulfamethylthiazole [CAS 515-59-3]
- QM-0018043-01 Sulfamethoxazole (sodium) (Standard) [CAS 4563-84-2]
- QM-0003138 Voclosporin-d4
- QM-0077043-01 Voclosporin [CAS 515814-01-4]
- QM-0147512-01 Vociprotafib [CAS 2172652-48-9]
- QM-0151261-01 Zefamenib [CAS 2938995-50-5]
- QM-0204688-01 Sulfamethoxazole-NO [CAS 29699-89-6]
- QM-0158030-01 Sulfamethoxazole-d4 [CAS 1020719-86-1]
- QM-0159731-01 Sulfamethoxypyridazine (Standard) [CAS 80-35-3]
- QM-0075831-01 Sulfamethoxazole (Standard) [CAS 723-46-6]
Other industry favorites
- QM-0052086 Sulfamethylthiazole [CAS 515-59-3]
- QM-0018043-01 Sulfamethoxazole (sodium) (Standard) [CAS 4563-84-2]
- QM-0063196-01 Vocacapsaicin (hydrochloride) [CAS 1931116-92-5]
- QM-0089021-01 Voclosporin (Standard) [CAS 515814-01-4]
- QM-0149115-01 Refametinib [CAS 923032-37-5]
- QM-0157431-01 Sulfamethazine [CAS 57-68-1]
- QM-0133916 Sulfamethoxypyridazine-d3 [CAS 1172846-03-5]
- QM-0125869 Sulfo-SANPAH (sodium) [CAS 144672-60-6]
- QM-0008049 Nivocasan [CAS 908253-63-4]
- QM-0007288 Paromamine [CAS 534-47-4]
Refametinib (R enantiomer) [CAS 923032-38-6]
Refametinib (R enantiomer) is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.